Richner, Justin M.

Modified mRNA vaccines protect against zika virus infection

Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L., Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W., Shresta, S., Pierson, T. C., et al. (2017) · Cell

Mosquito-borne diseases and controlSARS-CoV-2 and COVID-19 Research

Cited by 909

Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease

Richner, J. M., Jagger, B. W., Shan, C., Fontes, C. R., Dowd, K. A., Cao, B., Himansu, S., Caine, E. A., Nunes, B. T. D., Medeiros, D. B. A., et al. (2017) · Cell

Mosquito-borne diseases and controlSARS-CoV-2 and COVID-19 Research

Cited by 267

Global analyses revealed age‐related alterations in innate immune responses after stimulation of pathogen recognition receptors

Metcalf, T. U., Cubas, R. A., Ghneim, K., Cartwright, M. J., Grevenynghe, J. V., Richner, J. M., Olagnier, D. P., Wilkinson, P. A., Cameron, M. J., Park, B. S., et al. (2015) · Aging Cell

Immune Response and InflammationImmune responses and vaccinations

Cited by 189

mRNA Vaccines against Flaviviruses

Wollner, C. J., & Richner, J. M. (2021) · Vaccines

Mosquito-borne diseases and controlSARS-CoV-2 and COVID-19 Research

Cited by 44

A mRNA-LNP vaccine against Dengue Virus elicits robust, serotype-specific immunity

Wollner, C. J., Richner, M., Hassert, M. A., Pinto, A. K., Brien, J. D., & Richner, J. M. (2021) · bioRxiv (Cold Spring Harbor Laboratory)

Mosquito-borne diseases and controlSARS-CoV-2 and COVID-19 Research

Cited by 6